
Simplified N-SII Score Predicts Long-Term Survival in Hemodialysis Patients
Predicting mortality risk is vital for managing patients with end-stage renal disease. Monitoring outcomes through tools like the N-SII in hemodialysis survival is becoming essential for personalized care. Recent research introduced a composite scoring system called the nutritional-systemic immune inflammation (N-SII) score. This metric combines the Geriatric Nutritional Risk Index (GNRI) and the systemic immune inflammation index (SII). Consequently, it offers clinicians a more robust way to evaluate long-term prognosis.
The Clinical Impact of N-SII in Hemodialysis Survival
Researchers conducted a comprehensive review of 2,859 patients on maintenance hemodialysis. They aimed to identify indicators with superior prognostic accuracy. The study found that the N-SII composite score yielded an area under curve (AUC) of 0.850. This performance significantly outperformed the isolated use of GNRI or SII alone. Specifically, GNRI and SII achieved AUCs of 0.761 and 0.782, respectively. Moreover, the N-SII score proved effective in predicting mortality from various causes, including cardiovascular and cerebrovascular events.
The results emphasize the synergy between nutritional status and systemic inflammation. Malnutrition often exacerbates inflammatory responses, which then accelerates vascular damage. By integrating these two factors, the N-SII score provides a comprehensive risk profile. Therefore, healthcare providers can better stratify patients and prioritize those requiring aggressive nutritional support. Additionally, this score serves as a simple yet powerful tool for routine clinical practice.
Frequently Asked Questions
What components make up the N-SII score?
The N-SII score is a composite index. It incorporates the Geriatric Nutritional Risk Index (GNRI), which measures nutritional status, and the systemic immune inflammation index (SII), which reflects inflammatory levels.
Why is the N-SII score superior for predicting survival?
It integrates both nutrition and inflammation, which are two major factors driving mortality in dialysis patients. By combining them, it achieves higher accuracy than using either marker individually.
How does this study help doctors in clinical settings?
This score allows for better risk stratification. Consequently, doctors can identify high-risk patients more effectively and implement targeted interventions to improve long-term outcomes.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replacement for professional consultation. Refer to the latest local and national guidelines for clinical practice.
References
- Jiang Q et al. Simplified nutritional and inflammatory indicators for long-term survival from all-cause mortality in maintenance hemodialysis. Clin Nephrol. 2026 Apr 17. doi: 10.5414/CN111855. PMID: 41994879.
- Kobayashi I et al. Geriatric Nutritional Risk Index, a simplified nutritional screening index, is a significant predictor of mortality in chronic dialysis patients. Nephrol Dial Transplant. 2010 Oct;25(10):3361-6.
- Tang Y et al. Prognostic implications of systemic immune-inflammation index and systemic inflammation response index in hemodialysis patients. Front Immunol. 2024;15:1382970.

More from MedShots Daily

The N-SII composite score, merging GNRI and SII, significantly enhances the prediction of long-term survival for patients on maintenance hemodialysis....
Today

A 12-year retrospective study demonstrates that stenting for renal artery stenosis significantly improves blood pressure and renal function in high-risk pat...
Today

France will provide free reusable period products to women under 26 and those in poverty to combat period poverty and promote environmental sustainability....
Today

Recent research reveals significant sex differences in how the heart manages stroke volume and blood pressure during isometric exercise and metaboreflex act...
Today

A study evaluates a novel physiotherapist-integrated orthopaedic model, showing increased service capacity and high patient satisfaction in spine care....
Today

Setmelanotide, used for Bardet-Biedl Syndrome, frequently causes hyperpigmentation. Experts recommend baseline and annual dermatologic screening for patient...
Today